Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jamelah S. Al-Otaibi, Y.Sheena Mary & Y.Shyma Mary. (2023) Exploring the Detailed Spectroscopic Characteristics, Chemical and Biological Activity of Three Pyrone Derivatives Using Experimental and Theoretical Tools. Polycyclic Aromatic Compounds 43:1, pages 801-810.
Read now
Read now
Rahagir Salekeen, Joydip Barua, Punam Rani Shaha, Kazi Mohammed Didarul Islam, Md Emdadul Islam, Md Morsaline Billah & S. M. Mahbubur Rahman. (2022) Marine phycocompound screening reveals a potential source of novel senotherapeutics. Journal of Biomolecular Structure and Dynamics 40:13, pages 6071-6085.
Read now
Read now
Articles from other publishers (87)
Florian Malard, Christina Sizun, Aurélien Thureau, Ludovic Carlier & Ewen Lescop. (2023) Structural transitions in TCTP tumor protein upon binding to the anti-apoptotic protein family member Mcl-1. Journal of Biological Chemistry 299:7, pages 104830.
Crossref
Crossref
Yuanyi Yue, Qiang Zhang, Xueqing Wang & Zhengrong Sun. (2023) STAT3 regulates 5‐Fu resistance in human colorectal cancer cells by promoting Mcl‐1–dependent cytoprotective autophagy. Cancer Science 114:6, pages 2293-2305.
Crossref
Crossref
Seyedehdelaram Ghalehbandi, Jale Yuzugulen, Md Zahidul Islam Pranjol & Mohammad Hossein Pourgholami. (2023) The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF. European Journal of Pharmacology 949, pages 175586.
Crossref
Crossref
Caden G. Bonzerato & Richard J. H. Wojcikiewicz. (2023) Bok: real killer or bystander with non-apoptotic roles?. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Pedro Casado & Pedro R. Cutillas. (2023) Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine. Molecular & Cellular Proteomics 22:4, pages 100517.
Crossref
Crossref
Kelsey H. Fisher-Wellman, Miki Kassai, James T. Hagen, P. Darrell Neufer, Mark Kester, Thomas P. LoughranJr.Jr., Charles E. Chalfant, David J. Feith, Su-Fern Tan, Todd E. Fox, Johnson Ung, Gemma Fabrias, Jose’ Luis Abad, Arati Sharma, Upendarrao Golla, David F. Claxton, Jeremy J. P. Shaw, Debajit Bhowmick & Myles C. Cabot. (2023) Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid Leukemia. Cancers 15:6, pages 1883.
Crossref
Crossref
Ayman A. Dafa Allah, Hassan A. Yousif, Nafisa O. Hasaballa, Eman A. Elkhawad, Razaz B. Abdallah, Haram M. Ahmed, Anwar M. Abdelrahman, Salma Hago, Abdelgadir A. Abdelgadir, Abdulrahim A. Alzain & Elhadi M. Ahmed. (2023) Identification of phytochemicals from Tundub Capparis decidua (Forssk) Edgew seed oil as potential anticancer agents using gas chromatography-mass spectroscopy analysis, molecular docking, and molecular dynamics studies. Scientific African 19, pages e01517.
Crossref
Crossref
Jianda Yue, Yaqi Li, Fengjiao Li, Peng Zhang, Yimin Li, Jiawei Xu, Qianqian Zhang, Cheng Zhang, Xiao He, Ying Wang & Zhonghua Liu. (2023) Discovery of Mcl-1 inhibitors through virtual screening, molecular dynamics simulations and in vitro experiments. Computers in Biology and Medicine 152, pages 106350.
Crossref
Crossref
Carmen Avendaño & J. Carlos Menéndez. 2023. Medicinal Chemistry of Anticancer Drugs. Medicinal Chemistry of Anticancer Drugs
743
822
.
Caden G. Bonzerato, Katherine R. Keller, Jacqualyn J. Schulman, Xiaokong Gao, Laura M. Szczesniak & Richard J. H. Wojcikiewicz. (2022) Endogenous Bok is stable at the endoplasmic reticulum membrane and does not mediate proteasome inhibitor-induced apoptosis. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Md. Moinul, Samima Khatun, Sk. Abdul Amin, Tarun Jha & Shovanlal Gayen. (2022) Recent trends in fragment-based anticancer drug design strategies against different targets: A mini-review. Biochemical Pharmacology 206, pages 115301.
Crossref
Crossref
Ying Zhao, Yi Lan, Yugang Chi, Boping Yang & Chunyan Ren. (2022) Downregulation of Circ-CEP128 Enhances the Paclitaxel Sensitivity of Cervical Cancer Through Regulating miR-432-5p/MCL1. Biochemical Genetics 60:6, pages 2346-2363.
Crossref
Crossref
Lijia Chen, Alexandria M. Chan, Paul T. Wilder & Steven Fletcher. (2022) 1‐Sulfonylated 1,2,3,4‐tetrahydroquinoline‐6‐carboxylic acids as simple, readily‐accessible MCL‐1 inhibitors. Drug Development Research 83:8, pages 1879-1889.
Crossref
Crossref
Soo Jin Kim, Suntae Kim, Yong June Choi, U Ji Kim & Keon Wook Kang. (2022) CKD-581 Downregulates Wnt/β-Catenin Pathway by DACT3 Induction in Hematologic Malignancy. Biomolecules & Therapeutics 30:5, pages 435-446.
Crossref
Crossref
Julia Joung, Paul C. Kirchgatterer, Ankita Singh, Jang H. Cho, Suchita P. Nety, Rebecca C. Larson, Rhiannon K. Macrae, Rebecca Deasy, Yuen-Yi Tseng, Marcela V. Maus & Feng Zhang. (2022) CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity. Nature Communications 13:1.
Crossref
Crossref
Sapti PuspitariniNashi WidodoSri WidyartiYoga Dwi JatmikoMuhaimin Rifa’i. (2022) Polyherbal effect between Phyllanthus urinaria and Curcuma longa as an Anticancer and Antioxidant. Research Journal of Pharmacy and Technology, pages 671-678.
Crossref
Crossref
Zi-Yi Chen, Jie Li, Shu-Di Zhu, Zhi-Di Li, Jia-Lin Yu, Jie Wu, Chong Zhang & Ling-Hui Zeng. (2022) Harmine reinforces the effects of regorafenib on suppressing cell proliferation and inducing apoptosis in liver cancer cells. Experimental and Therapeutic Medicine 23:3.
Crossref
Crossref
Yousra Refaey, OlfatGamil Shaker, Ayman Abdelwahab, ImanAdel Mohamed Abdelmoneim & Fat’heyaMohamed Zahran. (2022) Diagnostic accuracy of human transcriptional activator (Myb) expression by ELISA technique versus immunohistochemistry in detecting salivary gland carcinomas. Journal of International Oral Health 14:1, pages 61.
Crossref
Crossref
Magdalena Klanova, Dmitry Kazantsev, Eva Pokorna, Tomas Zikmund, Jana Karolova, Matej Behounek, Nicol Renesova, Dana Sovilj, Cristina D. Kelemen, Karel Helman, Radek Jaksa, Ondrej Havranek, Ladislav Andera, Marek Trneny & Pavel Klener. (2022) Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas. Molecular Cancer Therapeutics 21:1, pages 89-99.
Crossref
Crossref
Zahra Fakhroueian, Sadegh Rajabi, Niloufar Salehi, Mostafa Rezaei Tavirani, Shokoofe Noori & Mitra Nourbakhsh. (2021) Anticancer properties of novel zinc oxide quantum dot nanoparticles against breast cancer stem-like cells. Anti-Cancer Drugs 33:1, pages e311-e326.
Crossref
Crossref
A-min Wang, Ru Qiu, Duo Zhang & Xiao-yan Zhao. (2022) Therapeutic effects of an innovative BS-HH-002 drug on pancreatic cancer cells via induction of complete MCL-1 degradation. Translational Oncology 15:1, pages 101288.
Crossref
Crossref
Kai Guo, Yixuan Liu, Lirui Tang & Quazi T.H. Shubhra. (2022) Homotypic biomimetic coating synergizes chemo-photothermal combination therapy to treat breast cancer overcoming drug resistance. Chemical Engineering Journal 428, pages 131120.
Crossref
Crossref
Heng Lin, Shon A. Koren, Gregor Cvetojevic, Peter Girardi & Gail V. W. Johnson. (2021) The role of BAG3 in health and disease: A “Magic BAG of Tricks”. Journal of Cellular Biochemistry 123:1, pages 4-21.
Crossref
Crossref
Christopher T. Su & J. Christine Ye. (2021) Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond. Journal of Hematology & Oncology 14:1.
Crossref
Crossref
Su-Jung Choi, Chi-Hyun Ahn, Kyoung-Ok Hong, Ji-Hoon Kim, Seong-Doo Hong, Ji-Ae Shin & Sung-Dae Cho. (2021) Molecular mechanism underlying the apoptotic modulation by ethanol extract of Pseudolarix kaempferi in mucoepidermoid carcinoma of the salivary glands. Cancer Cell International 21:1.
Crossref
Crossref
Christopher M. Gromisch, Glaiza L. A. Tan, Khristine Amber Pasion, Ann-Marie Moran, Matthew S. Gromisch, Mark W. Grinstaff, Francis J. Carr, Victoria L. M. Herrera & Nelson Ruiz-Opazo. (2021) Humanized anti-DEspR IgG4S228P antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis ratnu/nu model. BMC Cancer 21:1.
Crossref
Crossref
Mara Di Filippo & Marcus Baumann. (2021) Continuous Flow Synthesis of Anticancer Drugs. Molecules 26:22, pages 6992.
Crossref
Crossref
Byeol-Eun Jeon, Chan-Seong Kwon, Ji-Eun Lee, Keumok Moon, Jaeho Cha, Inmyoung Park, Sara Koh, Myunghee Yoon, Sang-Woo Kim & Jeong Nam Kim. (2021) Anticancer Activity of Continentalic Acid in B-Cell Lymphoma. Molecules 26:22, pages 6845.
Crossref
Crossref
Jian-Hong Lin, Kun-Ta Yang, Pei-Ching Ting, Yu-Po Luo, Ding-Jyun Lin, Yi-Shun Wang & Jui-Chih Chang. (2021) Gossypol Acetic Acid Attenuates Cardiac Ischemia/Reperfusion Injury in Rats via an Antiferroptotic Mechanism. Biomolecules 11:11, pages 1667.
Crossref
Crossref
Michela Carlet, Kerstin Völse, Jenny Vergalli, Martin Becker, Tobias Herold, Anja Arner, Daniela Senft, Vindi Jurinovic, Wen-Hsin Liu, Yuqiao Gao, Veronika Dill, Boris Fehse, Claudia D. Baldus, Lorenz Bastian, Lennart Lenk, Denis M. Schewe, Johannes W. Bagnoli, Binje Vick, Jan Philipp Schmid, Alexander Wilhelm, Rolf Marschalek, Philipp J. Jost, Cornelius Miething, Kristoffer Riecken, Marc Schmidt-Supprian, Vera Binder & Irmela Jeremias. (2021) In vivo inducible reverse genetics in patients’ tumors to identify individual therapeutic targets. Nature Communications 12:1.
Crossref
Crossref
Alena Malyukova, Dorina Ujvari, Elham Yektaei-Karin, Ana Zovko, Harsha S. Madapura, Marton Keszei, Noemi Nagy, Kourosh Lotfi, Niclas Björn, Jonas Wallvik, Minori Tamai, Thao T. T. Nguyen, Koshi Akahane, Takeshi Inukai, Leif Stenke & Daniel Salamon. (2021) Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells. Cell Death & Disease 12:10.
Crossref
Crossref
Pooja Mittal, Sujata Singh, Rajesh Sinha, Anju Shrivastava, Archana Singh & Indrakant Kumar Singh. (2021) Myeloid cell leukemia 1 (MCL-1): Structural characteristics and application in cancer therapy. International Journal of Biological Macromolecules 187, pages 999-1018.
Crossref
Crossref
Prasad Sulkshane, Sagar N. Pawar, Rohit Waghole, Sushil S. Pawar, Priyanka Rajput, Abhay Uthale, Swapnil Oak, Prajakta Kalkar, Harshada Wani, Rahul Patil, Sudhir Nair, Pallavi Rane & Tanuja Teni. (2021) Elevated USP9X drives early-to-late-stage oral tumorigenesis via stabilisation of anti-apoptotic MCL-1 protein and impacts outcome in oral cancers. British Journal of Cancer 125:4, pages 547-560.
Crossref
Crossref
Timo Burster, Rebecca Traut, Zhanerke Yermekkyzy, Katja Mayer, Mike-Andrew Westhoff, Joachim Bischof & Uwe Knippschild. (2021) Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Viktorija Juric, Lance Hudson, Joanna Fay, Cathy E. Richards, Hanne Jahns, Maïté Verreault, Franck Bielle, Ahmed Idbaih, Martine L. M. Lamfers, Ann M. Hopkins, Markus Rehm & Brona M. Murphy. (2021) Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation. Cell Death & Disease 12:8.
Crossref
Crossref
Shouhua Wang, Ting ting Su, Huanjun Tong, Weibin Shi, Fei Ma & Zhiwei Quan. (2021) CircPVT1 promotes gallbladder cancer growth by sponging miR-339-3p and regulates MCL-1 expression. Cell Death Discovery 7:1.
Crossref
Crossref
Hui San Chin & Nai Yang Fu. (2021) Physiological Functions of Mcl-1: Insights From Genetic Mouse Models. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Shuang Li, Jin Su, Wei Cai & Jian-xin Liu. (2021) Nanomaterials Manipulate Macrophages for Rheumatoid Arthritis Treatment. Frontiers in Pharmacology 12.
Crossref
Crossref
Karolina Stachyra, Monika Dudzisz-Śledź, Elżbieta Bylina, Anna Szumera-Ciećkiewicz, Mateusz J. Spałek, Ewa Bartnik, Piotr Rutkowski & Anna M. Czarnecka. (2021) Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies. International Journal of Molecular Sciences 22:12, pages 6305.
Crossref
Crossref
Y. Sheena Mary, Y. Shyma Mary, K. S. Resmi, S. Sarala, Rohitash Yadav & Ismail Celik. (2021) Modeling the structural and reactivity properties of hydrazono methyl-4H-chromen-4-one derivatives—wavefunction-dependent properties, molecular docking, and dynamics simulation studies. Journal of Molecular Modeling 27:6.
Crossref
Crossref
Donald J. AbrahamDavid A. DeGoey & Philip B. Cox. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
35
.
Haolan Wang, Ming Guo, Hudie Wei & Yongheng Chen. (2021) Targeting MCL-1 in cancer: current status and perspectives. Journal of Hematology & Oncology 14:1.
Crossref
Crossref
Supusson Pengnam, Samarwadee Plianwong, Prasopchai Patrojanasophon, Widchaya Radchatawedchakoon, Boon-ek Yingyongnarongkul, Praneet Opanasopit & Purin Charoensuksai. (2021) Synergistic Effect of Doxorubicin and siRNA-Mediated Silencing of Mcl-1 Using Cationic Niosomes against 3D MCF-7 Spheroids. Pharmaceutics 13:4, pages 550.
Crossref
Crossref
Zhi Xiong Chong, Swee Keong Yeap & Wan Yong Ho. (2021) Dysregulation of miR-638 in the progression of cancers. Pathology - Research and Practice 220, pages 153351.
Crossref
Crossref
Janine K. Tom, Michal M. Achmatowicz, Matthew G. Beaver, John Colyer, Ari Ericson, Tsang-Lin Hwang, Nancy Jiao, Neil F. Langille, Min Liu, Michael A. Lovette, Rahul P. Sangodkar, Srividya Sharvan Kumar, Simone Spada, Damith Perera, Jillian Sheeran, Kiersten Campbell, Timothy Doherty, David D. Ford, Yuan-Qing Fang, Emiliano Rossi, Gabriella Santoni, Sheng Cui & Shawn D. Walker. (2021) Implementing Continuous Manufacturing for the Final Methylation Step in the AMG 397 Process to Deliver Key Quality Attributes. Organic Process Research & Development 25:3, pages 486-499.
Crossref
Crossref
Elżbieta Pędziwiatr-Werbicka, Michał Gorzkiewicz, Sylwia Michlewska, Maksim Ionov, Dzmitry Shcharbin, Barbara Klajnert-Maculewicz, Cornelia E. Peña-González, Javier Sánchez-Nieves, Rafael Gómez, F. Javier de la Mata & Maria Bryszewska. (2021) Evaluation of dendronized gold nanoparticles as siRNAs carriers into cancer cells. Journal of Molecular Liquids 324, pages 114726.
Crossref
Crossref
Y. Sheena Mary, Y. Shyma Mary, K. S. Resmi & Ali Shokuhi Rad. (2021) Spectroscopic and computational study of chromone derivatives with antitumor activity: detailed DFT, QTAIM and docking investigations. SN Applied Sciences 3:2.
Crossref
Crossref
Yeong Jun Kim, Yuri Kim, Abhishek Kumar, Chan Woo Kim, Zsolt Toth, Nam Hyuk Cho & Hye-Ra Lee. (2021) Kaposi’s sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7. PLOS Pathogens 17:1, pages e1009179.
Crossref
Crossref
Manlio Tolomeo & Antonio Cascio. (2021) The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy. International Journal of Molecular Sciences 22:2, pages 603.
Crossref
Crossref
Radhika Bansal, Sagar Rakshit, Weiguo Han & Shaji Kumar. (2021) Modulation of Apoptosis Pathways in the Biology and Treatment of Multiple Myeloma. Oncology & Haematology 17:1, pages 48.
Crossref
Crossref
Hadley E. Sheppard, Alessandra Dall’Agnese, Woojun D. Park, M. Hamza Shamim, Julien Dubrulle, Hannah L. Johnson, Fabio Stossi, Patricia Cogswell, Josh Sommer, Joan Levy, Tanaz Sharifnia, Mathias J. Wawer, Behnam Nabet, Nathanael S. Gray, Paul A. Clemons, Stuart L. Schreiber, Paul Workman, Richard A. Young & Charles Y. Lin. (2021) Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity. Cell Reports Medicine 2:1, pages 100188.
Crossref
Crossref
Esraa Albasher Osman, Mohammed Abdalrahman Abdalla, Mohja Omer Abdelraheem, Mubarak Fadlalla Ali, Shima Albasher Osman, Yasmin Mohamed Tanir, Mohammed Abdelrahman, Walaa Ibraheem & Abdulrahim A. Alzain. (2021) Design of novel coumarins as potent Mcl-1 inhibitors for cancer treatment guided by 3D-QSAR, molecular docking and molecular dynamics. Informatics in Medicine Unlocked 26, pages 100765.
Crossref
Crossref
Jenna L. Carter, Katie Hege, Jay Yang, Hasini A. Kalpage, Yongwei Su, Holly Edwards, Maik Hüttemann, Jeffrey W. Taub & Yubin Ge. (2020) Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
Daozhi Xu, Peixin Dong, Ying Xiong, Rui Chen, Yosuke Konno, Kei Ihira, Junming Yue & Hidemichi Watari. (2020) PD-L1 Is a Tumor Suppressor in Aggressive Endometrial Cancer Cells and Its Expression Is Regulated by miR-216a and lncRNA MEG3. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Xinyou Yu, Feng Gao, Wei Li, Li Zhou, Wenbin Liu & Ming Li. (2020) Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Crossref
Rie Nishi, Hiroko Shigemi, Eiju Negoro, Miyuki Okura, Naoko Hosono & Takahiro Yamauchi. (2020) Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine. BMC Cancer 20:1.
Crossref
Crossref
Md Shahjaman, Fatema Tuz Zohora Jui, Tania Islam, Sukanta Das & Md Rezanur Rahman. (2020) Improved identification of core biomarkers and drug repositioning for ovarian cancer: an integrated bioinformatics approach. Network Modeling Analysis in Health Informatics and Bioinformatics 9:1.
Crossref
Crossref
Michelle E. Mulcahy, Eóin C. O’Brien, Kate M. O’Keeffe, Emilio G. Vozza, Neal Leddy & Rachel M. McLoughlin. (2020) Manipulation of Autophagy and Apoptosis Facilitates Intracellular Survival of Staphylococcus aureus in Human Neutrophils. Frontiers in Immunology 11.
Crossref
Crossref
Michele Stanchina, Deborah Soong, Binbin Zheng-Lin, Justin M. Watts & Justin Taylor. (2020) Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development. Cancers 12:11, pages 3225.
Crossref
Crossref
Andrew H. Wei, Andrew W. Roberts, Andrew Spencer, Aaron Seth Rosenberg, David Siegel, Roland B. Walter, Sean Caenepeel, Paul Hughes, Zach McIver, Khalid Mezzi, Phuong Khanh Morrow & Anthony Stein. (2020) Targeting MCL-1 in hematologic malignancies: Rationale and progress. Blood Reviews 44, pages 100672.
Crossref
Crossref
Katrina M. Lappin, Lindsay Davis, Kyle B. Matchett, Yubin Ge, Ken I. Mills & Jaine K. Blayney. (2020) A compound combination screening approach with potential to identify new treatment options for paediatric acute myeloid leukaemia. Scientific Reports 10:1.
Crossref
Crossref
Sebastian Kreimendahl & Joachim Rassow. (2020) The Mitochondrial Outer Membrane Protein Tom70-Mediator in Protein Traffic, Membrane Contact Sites and Innate Immunity. International Journal of Molecular Sciences 21:19, pages 7262.
Crossref
Crossref
Yang Gao, Pengbo Wen, Bin Chen, Guanshuo Hu, Lijun Wu, An Xu & Guoping Zhao. (2020) Downregulation of CDC20 Increases Radiosensitivity through Mcl-1/p-Chk1-Mediated DNA Damage and Apoptosis in Tumor Cells. International Journal of Molecular Sciences 21:18, pages 6692.
Crossref
Crossref
Parthiban Marimuthu, Jamoliddin Razzokov & Gofur Eshonqulov. (2020) Disruption of conserved polar interactions causes a sequential release of Bim mutants from the canonical binding groove of Mcl1. International Journal of Biological Macromolecules 158, pages 364-374.
Crossref
Crossref
Sheelagh Frame, Chiara Saladino, Craig MacKay, Butrus Atrash, Peter Sheldrake, Edward McDonald, Paul A. Clarke, Paul Workman, David Blake & Daniella Zheleva. (2020) Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer. PLOS ONE 15:7, pages e0234103.
Crossref
Crossref
Marc E. Healy, Yannick Boege, Michael C. Hodder, Friederike Böhm, Mohsen Malehmir, Anna-Lena Scherr, Jasna Jetzer, Lap Kwan Chan, Rossella Parrotta, Kurt Jacobs, Laure-Alix Clerbaux, Susanne Kreutzer, Andrew Campbell, Ella Gilchrist, Kathryn Gilroy, Ann-Katrin Rodewald, Hanna Honcharova-Biletska, Roman Schimmer, Karelia Vélez, Simone Büeler, Patrizia Cammareri, Gabriela Kalna, Anna S. Wenning, Kathy D. McCoy, Mercedes Gomez de Agüero, Henning Schulze-Bergkamen, Christoph S.N. Klose, Kristian Unger, Andrew J. Macpherson, Andreas E. Moor, Bruno Köhler, Owen J. Sansom, Mathias Heikenwälder & Achim Weber. (2020) MCL1 Is Required for Maintenance of Intestinal Homeostasis and Prevention of Carcinogenesis in Mice. Gastroenterology 159:1, pages 183-199.
Crossref
Crossref
Soo Jin Kim, U Ji Kim, Hae Yong Yoo, Yong June Choi & Keon Wook Kang. (2020) Anti-Cancer Effects of CKD-581, a Potent Histone Deacetylase Inhibitor against Diffuse Large B-Cell Lymphoma. International Journal of Molecular Sciences 21:12, pages 4377.
Crossref
Crossref
Ying-Chun Lin, Yu-Chia Chen, Rui-Yun Chen, Yi-Xuan Huang, Siang-Jyun Tu, Ji-An Liang, Yao-Ching Hung, Lian-Shung Yeh, Wei-Chun Chang, Wu-Chou Lin, Yin-Yi Chang, Shang-Wen Chen & Jan-Gowth Chang. (2020) Genomic Biomarkers of Survival in Patients with Adenocarcinoma of the Uterine Cervix Receiving Chemoradiotherapy. International Journal of Molecular Sciences 21:11, pages 4117.
Crossref
Crossref
Korrakod Petsri, Masashi Yokoya, Sucharat Tungsukruthai, Thanyada Rungrotmongkol, Bodee Nutho, Chanida Vinayanuwattikun, Naoki Saito, Takehiro Matsubara, Ryo Sato & Pithi Chanvorachote. (2020) Structure–Activity Relationships and Molecular Docking Analysis of Mcl-1 Targeting Renieramycin T Analogues in Patient-derived Lung Cancer Cells. Cancers 12:4, pages 875.
Crossref
Crossref
Sharvil P. Patel, R. Andrew Harkins, Michelle J. Lee, Christopher R. Flowers & Jean L. Koff. (2020) Using Informatics Tools to Identify Opportunities for Precision Medicine in Diffuse Large B-cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 20:4, pages 234-243.e10.
Crossref
Crossref
Xuan Zhang, Xingui Liu, Daohong Zhou & Guangrong Zheng. (2020) Targeting anti-apoptotic BCL-2 family proteins for cancer treatment. Future Medicinal Chemistry.
Crossref
Crossref
Marianna Abate, Agostino Festa, Michela Falco, Angela Lombardi, Amalia Luce, Anna Grimaldi, Silvia Zappavigna, Pasquale Sperlongano, Carlo Irace, Michele Caraglia & Gabriella Misso. (2020) Mitochondria as playmakers of apoptosis, autophagy and senescence. Seminars in Cell & Developmental Biology 98, pages 139-153.
Crossref
Crossref
Sarah T. Diepstraten, Catherine ChangLin TaiJia-nan GongPing Lan, Alexander C. Dowell, Graham S. Taylor, Andreas StrasserGemma L. Kelly. (2020) BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines. Blood Advances 4:2, pages 356-366.
Crossref
Crossref
Priya D. Gopal Krishnan, Emily Golden, Eleanor A. Woodward, Nathan J. Pavlos & Pilar Blancafort. (2020) Rab GTPases: Emerging Oncogenes and Tumor Suppressive Regulators for the Editing of Survival Pathways in Cancer. Cancers 12:2, pages 259.
Crossref
Crossref
Margarida Espadinha, Stuart J. Conway & Maria M.M. Santos. 2020. Small Molecule Drug Discovery. Small Molecule Drug Discovery
267
288
.
Insha Amin, Arif Ali, Bilal Ahmad Mir, Rayeesa Ali, Sheikh Bilal Ahmad, Manzoor Ur Rahman Mir, Wajhul Qamar, Azher Arafah, Muneeb U. Rehman & Tahir Maqbool Mir. 2020. Therapeutic Applications of Honey and its Phytochemicals. Therapeutic Applications of Honey and its Phytochemicals
1
18
.
Beatriz Pérez-Benavente, Alihamze Fathinajafabadi Nasresfahani & Rosa Farràs. 2020. Proteostasis and Disease. Proteostasis and Disease
3
28
.
Adoración G. Quiroga, Marta Cama, Natalia Pajuelo-Lozano, Amparo Álvarez-Valdés & Isabel Sanchez Perez. (2019)
New Findings in the Signaling Pathways of
cis
and
trans
Platinum Iodido Complexes’ Interaction with DNA of Cancer Cells
. ACS Omega 4:26, pages 21855-21861.
Crossref
Crossref
Guo Chen, Dongkyoo Park, Andrew T. Magis, Madhusmita Behera, Suresh S. Ramalingam, Taofeek K. Owonikoko, Gabriel L. Sica, Keqiang Ye, Chao Zhang, Zhengjia Chen, Walter J. Curran & Xingming Deng. (2019) Mcl-1 Interacts with Akt to Promote Lung Cancer Progression. Cancer Research 79:24, pages 6126-6138.
Crossref
Crossref
Xuan Zhang, Dinesh Thummuri, Yonghan He, Xingui Liu, Peiyi Zhang, Daohong Zhou & Guangrong Zheng. (2019)
Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-X
L
. Chemical Communications 55:98, pages 14765-14768.
Crossref
Crossref
Katja Seipel, Karin Schmitter, Ulrike Bacher & Thomas Pabst. (2019) Rationale for a Combination Therapy Consisting of MCL1- and MEK-Inhibitors in Acute Myeloid Leukemia. Cancers 11:11, pages 1779.
Crossref
Crossref
Qing Wang & Siguo Hao. (2019) A‑1210477, a selective MCL‑1 inhibitor, overcomes ABT‑737 resistance in AML. Oncology Letters.
Crossref
Crossref
Shu Yang, Yujia Mao, Huijun Zhang, Yan Xu, Jing An & Ziwei Huang. (2019) The chemical biology of apoptosis: Revisited after 17 years. European Journal of Medicinal Chemistry 177, pages 63-75.
Crossref
Crossref
Yu-Jin Kim, Beatrice Cubitt, Emily Chen, Mitchell V. Hull, Arnab K. Chatterjee, Yingyun Cai, Jens H. Kuhn & Juan C. de la Torre. (2019) The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors. Antiviral Research 169, pages 104558.
Crossref
Crossref
Aditi Sharma, Lawrence Boise & Mala Shanmugam. (2019) Cancer Metabolism and the Evasion of Apoptotic Cell Death. Cancers 11:8, pages 1144.
Crossref
Crossref
Mao-Chi Weng, Ming-Hsin Li, Jing Gung Chung, Yu-Chang Liu, Jeng-Yuan Wu, Fei-Ting Hsu & Hsin-Ell Wang. (2019) Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo. Biomedicine & Pharmacotherapy 116, pages 109032.
Crossref
Crossref
Li‑Hua Xu, Fei Zhao, Wen‑Wen Yang, Chu‑Wen Chen, Zhi‑Hao Du, Min Fu, Xi‑Yuan Ge & Sheng‑Lin Li. (2019) MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma. International Journal of Oncology.
Crossref
Crossref